INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2009

Glucosamine sulphate was not significantly better than placebo in reducing symptoms or progression in subgroups of hip osteoarthritis patients.

Researchers randomized 222 patients with hip osteoarthritis to receive either 1500 mg of oral glucosamine sulphate or placebo once daily for 2 years. Subgroup analyses examined radiographic severity, localized versus generalized osteoarthritis, pain level, medication use, baseline joint space width, and concomitant knee osteoarthritis. In the predefined subgroups, WOMAC pain, function, and joint space narrowing outcomes were similar between the glucosamine sulphate and placebo groups.

Study type
Randomized controlled trial (subgroup analyses)
Who was studied
222 patients with hip osteoarthritis
What was measured
WOMAC pain and function scores over 24 months, and joint space narrowing after 24 months

THE PAPER

Effect of glucosamine sulphate on joint space narrowing, pain and function in patients with hip osteoarthritis; subgroup analyses of a randomized controlled trial.

Rozendaal RM, Uitterlinden EJ, van Osch GJ, Garling EH, Willemsen SP, Ginai AZ, Verhaar JA, Weinans H, Koes BW, Bierma-Zeinstra SM. Osteoarthritis Cartilage, 2009.

PubMed 18848470 ↗DOI 10.1016/j.joca.2008.05.022 ↗

Bones & musclesOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.